These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 19710449)

  • 1. Pharmacy compounding of high-risk level products and patient safety.
    Mullarkey T
    Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S4-13. PubMed ID: 19710449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential risks of pharmacy compounding.
    Gudeman J; Jozwiakowski M; Chollet J; Randell M
    Drugs R D; 2013 Mar; 13(1):1-8. PubMed ID: 23526368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use.
    Formea CM; Weiss WT; McCluskey SV
    Am J Health Syst Pharm; 2008 Jul; 65(13):1266-9. PubMed ID: 18574018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.
    Hung JC; Augustine SC; Cheng KT; Green RL; Hopkins WM; Laven DL; Nelson BR; Petry NA; Ponto JA; Quinton TM; Swanson DP
    J Am Pharm Assoc (Wash); 2002; 42(5):789-98. PubMed ID: 12269713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated endotoxin testing program for high-risk-level compounded sterile preparations at an institutional compounding pharmacy.
    Cooper JF; Latta KS; Smith D
    Am J Health Syst Pharm; 2010 Feb; 67(4):280-6. PubMed ID: 20133532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration-2017.
    Schneider PJ; Pedersen CA; Scheckelhoff DJ
    Am J Health Syst Pharm; 2018 Aug; 75(16):1203-1226. PubMed ID: 29903709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterile Compounding Pharmacies: States That Do and Do Not Require Compliance With USP <797> Versus FDA 483s.
    Wilson M
    Ther Innov Regul Sci; 2016 May; 50(3):279-303. PubMed ID: 30227076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
    Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
    Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of Educational Offerings Provided by Compounding Support Companies in 2019.
    Stevens JT
    Int J Pharm Compd; 2019; 23(3):188-191. PubMed ID: 31085786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compounding for animal patients: contemporary issues.
    Lust E
    J Am Pharm Assoc (2003); 2004; 44(3):375-84; quiz 384-6. PubMed ID: 15191248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a sterile compounding training and competency program at a large academic medical center.
    Penzien CE; Tharp JC; Mulzer K; Rurka C; Abbas C; Chaffee BW
    Am J Health Syst Pharm; 2020 Dec; 77(24):2089-2100. PubMed ID: 33179045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National survey of quality assurance activities for pharmacy-compounded sterile preparations.
    Morris AM; Schneider PJ; Pedersen CA; Mirtallo JM
    Am J Health Syst Pharm; 2003 Dec; 60(24):2567-76. PubMed ID: 14735774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specialty compounding for improved patient care: 2006 national survey of compounding pharmacists.
    Huffman DC; Holmes ER
    Int J Pharm Compd; 2008; 12(1):74-82. PubMed ID: 23969574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instruction on compounded sterile preparations at U.S. schools of pharmacy.
    Hellums M; Alverson SP; Monk-Tutor MR
    Am J Health Syst Pharm; 2007 Nov; 64(21):2267-74. PubMed ID: 17959579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2.
    Martin M
    Int J Pharm Compd; 2018; 22(6):475-478. PubMed ID: 30384348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.